Piper Sandler on Crinetics (CRNX): 'We Are Buyers and Continue to Be Bullish'
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $97.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented: "CRNX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
